Prognostic Impact of Chronic Total Occlusions
1 other identifier
observational
91,154
1 country
1
Brief Summary
The purpose of this study is to determine the prognostic impact of the presence of chronic total occlusions (CTO) of the coronary arteries in patients undergoing coronary angiography and PCI.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2005
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2012
CompletedFirst Submitted
Initial submission to the registry
March 10, 2014
CompletedFirst Posted
Study publicly available on registry
March 12, 2014
CompletedMarch 12, 2014
March 1, 2014
7 years
March 10, 2014
March 11, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
All cause Mortality
3 years
Eligibility Criteria
The study is based on all patients who underwent diagnostic coronary angiography and were registered in SCAAR during the period 2005 to January 2012 . Only patients who were diagnosed with significant coronary artery disease were included in the analyses.
You may qualify if:
- Patient with angiographic diagnosis of significant CAD registered in SCAAR between January 2005 and january 2012
You may not qualify if:
- Previous CABG surgery
- Missing data on coronary anatomy
- Patients who underwent a procedure for ACS in whom the 100% occlusion was located in the same coronary artery as the culprit vessel
- Patients who underwent a procedure in the same vessel within the previous 3 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sahlgrenska University Hospital
Gothenburg, 41345, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Truls Råmunddal, MD PhD
Sahlgrenska University Hospital
- STUDY CHAIR
Elmir Omerovic, MD PhD
Sahlgrenska University Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Target Duration
- 3 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior consultant cardiologist, Director of the catheterization laboratory
Study Record Dates
First Submitted
March 10, 2014
First Posted
March 12, 2014
Study Start
January 1, 2005
Primary Completion
January 1, 2012
Study Completion
January 1, 2012
Last Updated
March 12, 2014
Record last verified: 2014-03